JP2018111825A5 - - Google Patents

Download PDF

Info

Publication number
JP2018111825A5
JP2018111825A5 JP2018034714A JP2018034714A JP2018111825A5 JP 2018111825 A5 JP2018111825 A5 JP 2018111825A5 JP 2018034714 A JP2018034714 A JP 2018034714A JP 2018034714 A JP2018034714 A JP 2018034714A JP 2018111825 A5 JP2018111825 A5 JP 2018111825A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018034714A
Other languages
English (en)
Other versions
JP2018111825A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018111825A publication Critical patent/JP2018111825A/ja
Publication of JP2018111825A5 publication Critical patent/JP2018111825A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 明細書に記載の発明。
JP2018034714A 2011-12-19 2018-02-28 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途 Pending JP2018111825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577223P 2011-12-19 2011-12-19
US61/577,223 2011-12-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014547146A Division JP6543467B2 (ja) 2011-12-19 2012-12-19 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途

Publications (2)

Publication Number Publication Date
JP2018111825A JP2018111825A (ja) 2018-07-19
JP2018111825A5 true JP2018111825A5 (ja) 2018-12-27

Family

ID=48668970

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014547146A Active JP6543467B2 (ja) 2011-12-19 2012-12-19 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途
JP2018034714A Pending JP2018111825A (ja) 2011-12-19 2018-02-28 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014547146A Active JP6543467B2 (ja) 2011-12-19 2012-12-19 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途

Country Status (28)

Country Link
US (1) US9475888B2 (ja)
EP (1) EP2794665B1 (ja)
JP (2) JP6543467B2 (ja)
KR (1) KR102135485B1 (ja)
CN (1) CN104144950B (ja)
AU (1) AU2012354229B2 (ja)
BR (1) BR112014014454B1 (ja)
CA (1) CA2856492C (ja)
CL (1) CL2014001651A1 (ja)
CO (1) CO7061069A2 (ja)
CY (1) CY1119899T1 (ja)
DK (1) DK2794665T3 (ja)
ES (1) ES2656613T3 (ja)
HK (1) HK1202883A1 (ja)
HR (1) HRP20180124T1 (ja)
HU (1) HUE036523T2 (ja)
IL (1) IL232905A (ja)
LT (1) LT2794665T (ja)
ME (1) ME02994B (ja)
MX (1) MX351104B (ja)
NO (1) NO2904345T3 (ja)
PL (1) PL2794665T3 (ja)
PT (1) PT2794665T (ja)
RS (1) RS56874B1 (ja)
RU (1) RU2617764C2 (ja)
SI (1) SI2794665T1 (ja)
WO (1) WO2013095279A1 (ja)
ZA (1) ZA201403640B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
US20150057226A1 (en) * 2012-03-26 2015-02-26 Dilafor Ab Method for treatment of labor arrest
CN104203256B (zh) * 2012-03-26 2017-11-24 迪乐方有限责任公司 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗
UA117912C2 (uk) * 2012-05-08 2018-10-25 Ділафор Аб Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк)
GB2515315A (en) * 2013-06-19 2014-12-24 Dilafor Ab New Processes
CN103788222B (zh) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
EP3137509A4 (en) * 2014-04-30 2018-03-14 Agency For Science, Technology And Research Heparan sulphates
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
US20230144378A1 (en) 2020-02-17 2023-05-11 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
TW202406559A (zh) 2022-05-03 2024-02-16 瑞典商迪拉佛公司 塔夫西肝素(tafoxiparin)之新穎醫藥用途
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
JPS63246396A (ja) * 1987-03-31 1988-10-13 Shiseido Co Ltd モノクロ−ナル抗体
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
SE9002550D0 (sv) * 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5250519A (en) 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
NZ330603A (en) 1996-10-15 2000-01-28 Toray Industries Hyaluronic acid derivatives used as cervical ripening agents
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
AU1173599A (en) * 1997-11-20 1999-06-15 Ikuo Yamashina Low-molecular heparin modification and remedy for skin ulcer
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
EP1059304B1 (en) 1998-02-26 2006-04-26 Seikagaku Corporation Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
US6492503B1 (en) * 1998-07-31 2002-12-10 Seikagaku Corporation Glycosaminoglycan and drug compositions containing the same
WO2000013019A1 (en) * 1998-08-26 2000-03-09 The Collaborative Group, Ltd. Receptor for underivatized, aqueous soluble beta-(1,3)-glucan
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
DK1319183T3 (da) * 2000-09-12 2009-05-18 Massachusetts Inst Technology Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US20040072796A1 (en) 2002-04-18 2004-04-15 Embury Stephen H. Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
JP2009507209A (ja) * 2005-07-22 2009-02-19 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア ヘパリン組成物およびセレクチン阻害
CA2616230A1 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
CA3086149A1 (en) * 2006-04-04 2007-10-11 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
EP2404939A3 (en) * 2006-05-25 2012-03-21 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
KR101561860B1 (ko) * 2007-11-02 2015-10-20 모멘타 파머슈티컬스 인코포레이티드 비항응고성 다당류 조성물
WO2009073184A1 (en) 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
MX2010010904A (es) 2008-04-04 2010-11-04 Univ Utah Res Found Eteres de glicosaminoglicosano semisinteticos alquilados, y metodos para elaborarlos y usarlos.
EP2411448B1 (en) * 2009-03-27 2013-03-20 Actamax Surgical Materials LLC Polyglycerol aldehydes
DK2419736T3 (da) 2009-04-16 2014-04-22 Momenta Pharmaceuticals Inc Fremgangsmåder til vurdering af aktivitet af en polysaccharidsammensætning
US20120108538A1 (en) 2009-06-30 2012-05-03 James Beeson Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
CA2769258A1 (en) * 2009-07-31 2011-02-03 Bayer Healthcare Llc Modified factor ix polypeptides and uses thereof
ES2551388T3 (es) * 2009-12-22 2015-11-18 Lifebond Ltd Modificación de agentes de entrecruzamiento enzimáticos para controlar las propiedades de las matrices entrecruzadas
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
US20150057226A1 (en) 2012-03-26 2015-02-26 Dilafor Ab Method for treatment of labor arrest
CN104203256B (zh) 2012-03-26 2017-11-24 迪乐方有限责任公司 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗

Similar Documents

Publication Publication Date Title
JP2019030304A5 (ja)
JP2020042034A5 (ja)
JP2020530297A5 (ja)
JP2021502066A5 (ja)
JP2022028828A5 (ja)
JP2022025124A5 (ja)
JP2020534795A5 (ja)
JP2021185136A5 (ja)
JP2021169491A5 (ja)
JP2020007340A5 (ja)
JP2020040981A5 (ja)
JP2019068846A5 (ja)
JP2021028398A5 (ja)
JP2021500894A5 (ja)
JP2021503478A5 (ja)
JP2017214405A5 (ja)
JP2016196495A5 (ja)
JP2020010717A5 (ja)
JP2018135352A5 (ja)
JP2019142968A5 (ja)
JP2018154848A5 (ja)
JP2018111825A5 (ja)
JP2021038271A5 (ja)
JP2016028081A5 (ja)
JP2019536002A5 (ja)